L-serine to be used as a drug for preventing and/or treating an inflammatory response of the skin
US10052297B2 · kind B2 · utility
0Cited by
2References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 1, 2010 |
| Grant date | Aug 21, 2018 |
| Priority date | — |
| Expiry date | Jul 1, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61Q19/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of L-serine as a drug for preventing and/or treating an inflammatory response of the skin caused by the overexpression and/or the overactivation of PAR2 receptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.